2020 80% in Every Community Conference & NCCRT Annual Meeting
November 16-17, 2020
Monday, Nov. 16, 1:00 to 4:45 PM ET
Tuesday, Nov 17, 1:00 to 4:30 PM ET
Each year the NCCRT membership, a collaboration of over 150 medical, advocacy, government, and corporate organizations, convenes to work together on our shared goal to increase colorectal cancer screening awareness and utilization, thereby reducing deaths from this highly preventable and curable disease. This year the event will be held virtually and will include the 80% in Every Community Conference and the annual meeting of the membership with select conference sessions open to the public.
The 2020 80% in Every Community Conference and NCCRT Annual Meeting will feature presentations by nationally known experts, thought leaders, and decision makers on colorectal cancer screening policy and delivery, with opportunities to network and learn from each other. Task group sessions will be held in the weeks prior to the meeting, dates to be determined.
Panel Session: The COVID-19 Pandemic & Impacts To Colorectal Cancer Screening
Amidst March 2020, National Colorectal Cancer Awareness Month, medical providers, and healthcare systems across the country halted many “non-essential” healthcare services and procedures in hopes of significantly reducing the spread of COVID-19, including colorectal cancer screening. The action caused immediate and longer-term impacts on our field, including delayed and canceled screenings, missed diagnoses, and a further exacerbation in disparities and burdens felt by under-represented communities – all of which will lead to excess deaths from colorectal cancer. This session will explore how the pandemic affects colorectal cancer screening at different intersections of the healthcare system.
- Moderator and Presenter: Folasade (Fola) May, MD, PhD, Assistant Professor of Medicine, Director of Quality Improvement, UCLA Health; Veterans Affairs
- Gastroenterology: Mark Pochapin, MD, President of the American College of Gastroenterology; Gastroenterology Division Director at NYU Langone Health
- Hospital Systems: Jay Bhatt, DO, Principal, JDB Strategies LLC, and former SVP & Chief Medical Officer of the American Hospital Association
- Primary Care: Carmen Guerra, MD, MSCE, FACSP, Vice-Chair of Diversity and Inclusion, Department of Medicine; Associate Director of the Office of Diversity, Abramson Cancer Center; University of Pennsylvania
- Community Health Centers: Cheryl Modica, PhD, MPH, BSN, Director, Quality Center, National Association of Community Health Centers
*During the Q&A section of this session, some questions and responses included discussion around the role of CT colonography as a screening option during the pandemic. CT colonography remains an important, safe, and recommended screening option during the COVID-19 pandemic.
Concurrent Session 1: Innovative Strategies to Reach Patients for Colorectal Cancer Screening During COVID-19
This session will move beyond describing the challenges of reaching patients for colorectal cancer screening amidst the COVID-19 pandemic to showcasing innovative healthcare-based solutions. Examples will include the use of animated video education to encourage FIT completion among the uninsured and under-insured; early insights from the Colorectal Cancer Alliance’s new, multi-city Screening During COVID campaign and screening navigation tool; and process recommendations for prioritizing patients for colonoscopy following the resumption of routine endoscopic exams in New York City.
- Laura Makaroff, DO, Senior Vice President, Prevention and Early Detection, American Cancer Society, Inc.; NCCRT Steering Committee (Moderator)
- Renay Caldwell, Director of Navigation Services, Colorectal Cancer Prevention Network
- Michael Sapienza, CEO, Colorectal Cancer Alliance
- David A. Greenwald, MD, FACG, Director of Clinical Gastroenterology and Endoscopy, the Mount Sinai Hospital; President-elect, American College of Gastroenterology; Co-chair, NCCRT Public Awareness & Social Media Strategic Priority Team
Concurrent Session 2: Early Age Onset Colorectal Cancer Screening Updates
Our understanding of early age onset colorectal cancer (EAO CRC) improves with each passing year. Leading researchers, non-profit organizations, and national agencies have invested considerable time, funding, discussion, and other resources toward coordinating a comprehensive approach to tackling this alarming issue. This session will dive into some of the latest research and trends related to EAO CRC and explore future steps we can take to address this issue.
- Heather Hampel, MS, LGC, Associate Director, The Ohio State University Comprehensive Cancer Center, Human Genetics, NCCRT Steering Committee (Moderator)
- Rebecca L. Siegel, MPH, Scientific Director, Surveillance Research, American Cancer Society, Inc.
- Samir Gupta, MD, MSCS, AGAF, Professor, Division of Gastroenterology, Department of Internal Medicine; Co-Lead, Cancer Control Program, Moores Cancer Center; University of California San Diego; Chief, GI Section, San Diego Veterans Affairs Healthcare System
- Jordan J. Karlitz, MD, Director, GI Hereditary Cancer and Genetics Program, Tulane University Cancer Center; NCCRT Steering Committee
Concurrent Session 3: Strategies to Promote Colorectal Cancer Screening in Under-represented Communities
This session will showcase evidence-based and emerging best practices for promoting colorectal cancer screening in under-represented communities. Examples will include the use of community theater to raise awareness and promote screening, outreach strategies to reach individuals experiencing homelessness, use of virtual human technology to communicate health messages in diverse populations, and strategies to reach Black men for screening.
- Joseph E. Ravenell, MD, MS, Associate Professor of Medicine & Population Health; Associate Dean of Diversity Affairs and Inclusion; Director, Center for the Elimination of Cancer Disparities; Perlmutter Cancer Center, New York University School of Medicine, NCCRT Steering Committee (Moderator)
- Janice Krieger, PhD, Professor, Department of Advertising; Director, STEM Translational Communication Center, University of Florida
- Tracy Russell, RN, MSN, BSN, Population Health Nurse, Health Care for the Homeless
- Charles R. Rogers, PhD, MPH, MS, MCHES, Assistant Professor, Department of Family & Preventive Medicine, University of Utah School of Medicine
- Roshanda Chenier, EdD, Project Manager and Outreach Officer/Community Engagement Leader, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Panel Session: Systemic Racism & Impacts To Health, Health Care, And Colorectal Cancer
This conversational panel will explore systemic racism’s alarming impact on health, health care, and in turn, colorectal cancer. Join us for this timely and important discussion given the national and community spotlights on how systemic racism affects Black communities following the tragic police killings and racial health inequities resulting from COVID-19 in 2020.
- Steven Itzkowitz, MD, FACP, FACG, AGAF, Professor of Medicine and Oncological Sciences, Icahn School of Medicine at Mount Sinai, NCCRT Steering Committee (Moderator)
- Rhea Boyd, MD, MPH, Pediatrician and Child Advocate; Director of Equity and Justice for The California Children’s Trust; Chief Medical Officer, San Diego 211, San Diego, CA
- Marcella Nunez-Smith, MD, MHS, Associate Professor, Internal Medicine, Public Health, and Management; Founding Director, the Equity Research and Innovation Center; Director, Center for Research Engagement; Yale School of Medicine
- Darrell M. Gray, II, MD, MPH, Assistant Professor of Medicine; Director of Community Engagement and Equity in Digestive Health; Medical Director of Endoscopy and Gastroenterology Services; Deputy Director, Center for Cancer Health Equity; The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Concurrent Session 4: State-based Colorectal Cancer Screening Updates & Innovations
This session will focus on colorectal cancer screening policy and practice implementation at the state level. Participants will learn about current grant-funded programs, policy successes, and state-based coalition-building efforts to improve colorectal cancer screening by working with community health centers, health systems, state legislatures, and other critical public health stakeholders.
- Xavier Llor, MD, PhD, Co-Director, Cancer Genetics and Prevention Program; Medical Director, Colorectal Cancer Prevention Program; Medical Director of Cancer Screening and Prevention; Yale University Cancer Center, NCCRT Steering Committee (Moderator)
- Amy DeGroff, PhD, MPH, Senior Health Scientists, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention
- Lance Barbour, Senior State and Local Campaigns Manager, American Cancer Society Cancer Action Network, Inc.
- Molly McDonnell, Director of Advocacy, Fight Colorectal Cancer
- Donald Warne, MD, MPH, Associate Dean of Diversity, Equity and Inclusion; Director of the Indians Into Medicine and Master of Public Health Programs, and Professor of Family and Community Medicine; University of North Dakota